advertisement

---

Journal of Ocular Pharmacology and Therapeutics 7

Showing records 1 to 7 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

10915 Inhibition of endothelin-1 and KC1-induced increase of [Ca ²⁺]_i by antiglaucoma drugs in cultured A7r5 vascular smooth-muscle cells
Wu K-Y; Wang H-Z; Hong S-J
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 201-209

---

10700 Effects of carteolol hydrochloride on the in vitro production of LPS-induced proinflammatory cytokines by murine macrophage
Kawai K; Kuwahara K; Oizumi N; Kitagaki H; Fujisawa S
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 237-245

---

10816 Efficacy of Bimatoprost 0.03 Percent in Untreated Glaucoma and Ocular Hypertension Patients: Results from a Large Community-Based Clinical Trial
Quinones R; Severin T; Mundorf T
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 115-122

---

10839 Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca²⁺ mobilization and MAP kinase activation
Sharif NA; Crider JY; Husain S; Kaddour Djebbar I; Ansari HR; Abdel Latif AA
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 437-55

---

10881 Latanoprost eye drops increase concentration of glycosaminoglycans in posterior rabbit sclera
Trier K; Ribel Madsen SoM
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 185-188

---

10801 Structural requirements of flavonoids for increment of ocular blood flow in the rabbit and retinal function recovery in rat eyes
Park Y-H; Xu X-R; Chiou GCY
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 189-200

---

10810 Sterility of Glaucoma Medications among Chronic Users in the Community
Porges Y; Rothkoff L; Glick J; Cohen S
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 123-128

---